HealthTechConnect Global

???Revolutionizing IVF!?Conceivable Life Sciences is on a mission to make?IVF more accessible and affordable—and they’re doing it with the?world’s first automated IVF lab. ???? Now, with a?$18M Series A?led by?ARTIS Ventures?(bringing total funding to?$39M), Conceivable is set to transform fertility treatment ahead of its?2026 US launch. ????? ???Why does this matter??IVF labs have remained largely?manual?and?artisanal?for decades. Conceivable is?changing the game?with automation, AI, robotics, and machine vision—bringing IVF into the future. As?Alejandro Chavez-Badiola, MD, PhD, Chief Product Officer, explains: ???“Despite significant clinical advances, IVF labs remain largely manual and lacking the kind of automation that has transformed other branches of advanced medicine.” ???“Even in early testing, our clinical outcomes rival the best IVF labs in the world. As we expand access, we anticipate even better results, heralding a new chapter in IVF.” ???A game-changer for fertility care—and a major step toward democratizing access to IVF. ?? #Femtech #IVF #FertilityInnovation #HealthTech #AI #Automation #Funding #FutureOfHealthcare

???Big news in femtech!?Lady Technologies, the company behind the fertility tracker and pelvic floor trainer?kegg, has just secured a?$6.5M Series A?to expand its vaginal health platform! ???? Led by?Relentless Consumer Partners, this funding will push Lady Technologies beyond conception insights—giving women?unparalleled access?to their intimate health data. Kristina Cahojova Founder & CEO, shared: ???"I was shocked that women were being asked to determine changes in cervical mucus using their fingers. I set out to build a technology-driven product, to change the status quo and enable every woman to have total agency over her own body." ???"Our unique form factor allowed us to collect the largest dataset on cervical fluid changes, enabling us to develop the first comprehensive vaginal health platform." This is a?huge?step forward for?women’s health innovation—data-driven, tech-powered, and breaking barriers. ???? #Femtech #WomenInTech #Innovation #VaginalHealth #Funding #HealthTech

???Improving access to fertility care starts with reducing costs. Granata Bio?is committed to making fertility treatments more affordable by identifying and developing?new therapeutic solutions. With their latest funding, they are?accelerating the development of their current and future pipeline?to better serve fertility patients across North America. ???“Granata Bio is committed to improving access for fertility patients by identifying and developing new therapeutic solutions. With this new funding, we are well-positioned to accelerate the development of our current and future pipeline.”?–?Evan Sussman Bio Since its founding in 2018, Granata Bio has worked to?reduce the cost of IVF medications, which have increased by?50%?since 2014, while fertility insurance coverage in the U.S. remains?patchy—leaving many patients bearing the burden of steep costs or unable to afford treatment altogether. Granata Bio’s goal is to change that, providing?greater access to affordable fertility care?for all. ?? #FertilityCare #IVF #WomensHealth #HealthcareInnovation #AccessToCare #GranataBio

???Big news for women with chronic hormonal conditions! Allara, the virtual care platform built to support women with?PCOS,?endometriosis, and other complex hormonal and gynecologic conditions, has just raised?$26 million in Series B funding, bringing their total funding to?$38.5 million! ???“Allara was built for the tens of millions of women living with complex hormonal and gynecologic conditions across the U.S., myself included.”?–?Rachel Blank, This funding will help expand?virtual care?for women who deserve better support in managing their conditions.?PCOS, endometriosis, and other hormonal issues?are often misunderstood, but Allara is working to change that—providing care that’s personalized, accessible, and empowering. ?? #WomensHealth #FemTech #HealthInnovation #PCOS #Endometriosis #VirtualCare

???Menopause should be understood—not suffered through. For too long, women have been left to?"suffer" through menopause?due to a?lack of knowledge, support, and solutions. That’s why?Bayer | Consumer Health?is stepping up with?CanesMeno?—marking its first-ever entry into the menopause category in the UK. ???"With CanesMeno?, we aim to educate, destigmatise, and offer community support to empower more women to take more control of their health and well-being."?– Daria Costantini | Consumer Health. By combining?education, destigmatisation, and support, CanesMeno? is tackling menopause head-on—giving women the tools they need to navigate this stage of life with?confidence and control.??? Let’s move beyond?"suffering"?and towards?empowerment?in menopause care. ?? #MenopauseAwareness #WomensHealth #HealthInnovation #CanesMeno #BreakingTheStigma

???Fertility care shouldn’t leave patients feeling lost and alone. That’s why myStoria?has launched in Canada—a new?fertility education and support platform?designed to help individuals navigate their journey to parenthood with?less time, cost, and life disruption. ???"We created myStoria to bridge the gaps in care and support patients every step of the way."?– Jessica Chalk. Fertility journeys can be overwhelming, but?better support, education, and guidance?can make all the difference. This is a huge step forward for patient-centered fertility care in Canada! ?? #FertilityCare #WomensHealth #HealthcareInnovation #PatientSupport #myStoria

???A world-leading AI trial is set to transform breast cancer detection in the UK!??? Nearly?700,000 women across England?will take part in the?EDITH trial?(‘Early Detection using Information Technology in Health’), announced today by the?UK Government’s Department of Health and Social Care. Backed by?￡11 million?from the?NIHR, this groundbreaking study will explore how?AI can detect breast cancer earlier, leading to?faster, more accurate diagnoses. ???“This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most.”?– Lucy Chappell Adviser, DHSC & CEO, NIHR. With early detection being?key to survival, harnessing AI for breast cancer screening could be a?game-changer?for women’s health. ?? #BreastCancerAwareness #AIinHealthcare #WomensHealth #EarlyDetection #HealthcareInnovation

???At-home fertility injections are one of the biggest challenges patients face—but what if they didn’t have to do it alone? ???86% of fertility patients?say?at-home injections?are the hardest part of their journey. Yet, most clinics are?closed during critical evening injection times, leaving patients to manage on their own. That’s where?Dandi Fertility?steps in. Their service fills a crucial gap, ensuring women have?professional support when they need it most. ???Fertility care is evolving—with?40% of employers?now offering fertility benefits, up from 30% just a few years ago. ???"We're creating the infrastructure to support this growing need, ensuring women have access to professional care during the most critical moments of their fertility journey."?– Jake Kent . This is the kind of?patient-first innovation?that makes a real difference. Let’s keep pushing for?better support in fertility care.??? #FertilityCare #WomensHealth #HealthcareInnovation #PatientSupport #FemTech

???Big news for women’s pelvic health!??? Mayo Clinic?is bringing its?overactive bladder educational content?to the?Axena Health Leva app, alongside the?FDA-cleared Leva pelvic health device—a major step in empowering women with evidence-based information and treatment. But that’s not all. ?? Mayo Clinic is also?investing in Axena Health, fueling efforts to advance?women’s pelvic healththrough: ? Future?innovations?in treatment ? Expanded?educational initiatives ? More?evidence-based solutions?for conditions like urinary incontinence ???“Education is a cornerstone of effective care, particularly for conditions like urinary incontinence where stigma and misinformation often hinder treatment.”?– Samantha (Mandy) Pulliam, CMO, Axena Health. This collaboration signals?real momentum?in breaking down barriers, tackling stigma, and ensuring?more women get the care they need.???? #WomensHealth #PelvicHealth #FemTech #Innovation #HealthcareAdvancement

???Meet the trailblazing female innovators shaping 2025!??? Innovate UK?has just announced the?50 female-founded startups?receiving its prestigious?‘Women in Innovation’ Awards?– with each founder securing?￡75,000?in funding. ?? Among them,?FemTech is making waves???, with four incredible startups set to share in the?￡3.75 million?award: ???The Daughters of Mars?– Revolutionizing period care ???Boost?– Innovating breast prostheses ???BirthGlide?– Advancing medical devices for childbirth ???Bloomful?– Supporting gynae health with a cutting-edge app This recognition isn’t just about funding—it’s about?driving real change?in women’s health, breaking down barriers, and bringing long-overdue innovation to the forefront. ??? Congrats to all the winners! Let’s keep pushing for progress in?FemTech & women’s health innovation.??? #WomenInInnovation #FemTech #WomensHealth #Innovation #StartupSuccess